|

E-Type - Early Wear of Polyethylene Liners Used in DMC

RECRUITINGPhase 4Sponsored by Uppsala University
Actively Recruiting
PhasePhase 4
SponsorUppsala University
Started2026-10-08
Est. completion2033-10-01
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted

Summary

This is a single-centre, randomized, double-blinded controlled non-inferiority trial that will be conducted at the Orthopaedic Department at Uppsala University Hospital, Uppsala. The aim of the study is to evaluate the performance of a dual mobility acetabular component with a Vitamin E-infused highly crosslinked polyethylene (VEPE) liner compared to a conventional polyethylene (PE) liner in adult patients with symptomatic osteoarthritis, osteonecrosis, or dysplasia of the hip requiring a hip replacement. The assessments will focus on early wear, cup migration, adverse events, and clinical outcomes. Measurements will be conducted using Computed Tomography Radiostereometric Analysis (CT-RSA) instead of traditional radiostereometric analysis. The study hypothesis is that the PE liner will be non-inferior to the VEPE liner in terms of early wear over a two-year period.

Eligibility

Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 18-75 years
* Written informed consent
* Eligible for a Total Hip Arthroplasty according to local guidelines and appropriate candidate for a dual mobility concept
* Diagnosis: Symptomatic osteoarthritis, osteonecrosis, or dysplasia of the hip requiring a hip replacement

Exclusion Criteria:

* Confirmed dementia or cognitive impairment
* Unwillingness to give written informed consent
* Age \<18 or \>75 years
* Hip fracture (traumatic or pathological) in need of a Total Hip Arthroplasty
* Patients who are not deemed suitable for a THA with a Dual Mobility Cup according to local guidelines and routines
* Comorbidities that are contraindicators for hip replacement surgery

Conditions4

ArthritisDysplasia; HipOsteoarthritisOsteonecrosis

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.